Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haass

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brainP J Kahle, M Neumann, L Ozmen, et al.
Molecular Psychiatry|June 10, 2015
Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatmentM Brendel, A Jaworska, J Herms, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatmentT Dejaegere, L Serneels, M K Schäfer, et al.
The American Journal of Pathology|December 26, 2001
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse modelP J Kahle, M Neumann, L Ozmen, et al.
Journal of Neurochemistry|July 2, 1998
Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brainF Oyama, N Sawamura, K Kobayashi, et al.
Molecular Psychiatry|September 25, 2013
Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structuresS Liebscher, R M Page, K Käfer, et al.
Neurobiology of Disease|January 1, 1997
Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissueM B Podlisny, M Citron, P Amarante, et al.
Acta Neurologica Scandinavica. Supplementum|March 23, 2001
Mutation of conserved aspartates affect maturation of presenilin 1 and presenilin 2 complexesG Yu, F Chen, M Nishimura, et al.
The Journal of Biological Chemistry|June 17, 2000
Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexesG Yu, F Chen, M Nishimura, et al.
The Journal of Biological Chemistry|September 25, 1999
A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signalingH Steiner, K Duff, A Capell, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brainP J Kahle, M Neumann, L Ozmen, et al.
Molecular Psychiatry|June 10, 2015
Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatmentM Brendel, A Jaworska, J Herms, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatmentT Dejaegere, L Serneels, M K Schäfer, et al.
The American Journal of Pathology|December 26, 2001
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse modelP J Kahle, M Neumann, L Ozmen, et al.
Journal of Neurochemistry|July 2, 1998
Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brainF Oyama, N Sawamura, K Kobayashi, et al.
Molecular Psychiatry|September 25, 2013
Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structuresS Liebscher, R M Page, K Käfer, et al.
Neurobiology of Disease|January 1, 1997
Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissueM B Podlisny, M Citron, P Amarante, et al.
Acta Neurologica Scandinavica. Supplementum|March 23, 2001
Mutation of conserved aspartates affect maturation of presenilin 1 and presenilin 2 complexesG Yu, F Chen, M Nishimura, et al.
The Journal of Biological Chemistry|June 17, 2000
Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexesG Yu, F Chen, M Nishimura, et al.
The Journal of Biological Chemistry|September 25, 1999
A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signalingH Steiner, K Duff, A Capell, et al.
Pageof 11